By: IPP Bureau
Last updated : May 11, 2026 6:41 pm
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
The 6th Drug Safety Symposium 2026 – India Chapter, scheduled to be held in Mumbai on June 24 and 25, 2026, will convene leading stakeholders from across the pharmacovigilance (PV) ecosystem to examine whether current technological advancements are genuinely improving patient safety outcomes.
The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory authorities, and technology organisations.
Centred around the theme, “Beyond Algorithms & Assumptions, What Actually Matters in PV?”, the symposium aims to shift the industry conversation beyond artificial intelligence (AI) and automation toward practical decision-making, operational clarity, and measurable real-world impact in pharmacovigilance systems.
The theme has been developed following discussions with more than 30 pharmacovigilance professionals representing pharmaceutical companies, contract research organisations (CROs), and technology providers. According to the organisers, a recurring concern emerging from these conversations is that despite the rapid adoption of AI-enabled systems, organisations continue to face challenges related to process alignment, accountability, and translating safety data into meaningful regulatory and clinical decisions.
The symposium agenda will address several emerging and ongoing challenges in pharmacovigilance, including evolving regulatory expectations, the complexity of social media-driven literature monitoring, implementation gaps in additional risk minimisation measures (aRMMs) in India, and the growing need to improve the reliability and actionability of real-world data.
Discussions will also focus on issues such as signal prioritisation, clarity in pharmacovigilance agreements between pharmaceutical companies and CROs, and maintaining an effective balance between automation and human oversight in safety operations.
Designed as a practical and discussion-oriented forum, the event will feature workshops, leadership roundtables, and panel discussions intended to deliver actionable insights for industry stakeholders.
The symposium is being guided by a scientific committee comprising senior industry experts, including Dr. Rahul Somani, Prasad Deshmukh, Dr. Rajendra Kasi, Dr. Siva Kumar Budha, and Vikram K.
Organisers said the committee’s expertise is expected to ensure alignment between global pharmacovigilance best practices and region-specific industry challenges.